Organizational Excellence SERVICES
Explore our Organizational Excellence Services
Embark on a transformative journey with Halloran’s Organizational Excellence Services, where innovative solutions redefine industry standards. Our streamlined approach prioritizes precision in leadership and strategic execution, optimizing every facet from organizational planning to operational excellence. Delve into data-driven insights that empower informed decisions, offering a comprehensive understanding of transformative intricacies. Forge collaborative partnerships with a dedicated team, overcoming challenges and achieving milestones that set new benchmarks in organizational transformation. Trust in our reliability at every stage, where accuracy, compliance, and security ensure the integrity of your organizational data. Elevate your leadership potential with Halloran’s tailored solutions, pioneering the future of excellence in organizational transformation. Ready to redefine industry standards? Explore Halloran today, where innovation and transformative expertise converge to open doors to boundless possibilities!
Organizational Excellence Services
Change management is the compass guiding organizations through the tumultuous waters of technological evolution, but unfortunately, it can be overlooked. During a recent eClinical Engage panel, “Everyone Needs Validation: Navigating and Executing the Change Management Process,” Karen Travers, Principal Consultant at Halloran, joined Venu Mallarapu, VP of Global Strategy and Operations at eClinical Solutions, and […]
The Cost and Challenges of Drug Development The American Journal of Health Economics (AJHE) previously estimated the cost of bringing a new drug to market is US$ 802 million based on the research and development of 68 drugs launched by 11 pharmaceutical companies.1 But new estimates suggest these costs have risen even more to a […]
Recently at CORE West – a Clinical Operations Retreat for Executives produced by Halloran Consulting Group – clinical operations executives and life science leaders gathered to discuss opportunities to modernize clinical trials. A particular discussion engaged the audience with an interactive workshop, gathering feedback to share with the U.S. Food and Drug Administration (FDA) on […]